EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sonoselective Transfection of Glioma Endothelium

Anna C Debski, Catherine M Gorick iD, Victoria R Breza, Jackson Tirrell iD, Krishan Perumal, Katherine M Nowak, Ji Song, Natasha D Sheybani iD, Richard J Price iD

Advanced Science · 2026

DOI: 10.1002/advs.76997 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Anna C Debski und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia, USA. Hauptthemen laut MEDLINE: Transfection, Brain Neoplasms, Glioma, Genetic Therapy. Die Arbeit nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIBIB NIH HHS, NCI NIH HHS, UVa Comprehensive Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The blood‐brain and blood‐tumor barriers impede therapeutic delivery to glioblastoma (GBM). Furthermore, dysfunctional endothelial cells in GBM enable an immunosuppressive tumor microenvironment (TME) and enhance therapeutic resistance. However, the significance of endothelial dysfunction for GBM progression also positions the endothelium as a rich target for gene therapy. Here, we leveraged the presence of exofacial thiols (SH) on cells within the TME and developed polymeric, plasmid‐bearing, densely PEGylated, polyethyleneimine nanoparticles (NPs) functionalized with free thiol groups to facilitate targeting and transfection (SH‐NPs). Delivering SH‐NPs to GBM with focused ultrasound (FUS) elicited exceptionally high tropism for GBM endothelium (>70% efficiency), significantly surpassing that achieved via convection‐enhanced delivery (CED). “Sonoselective,” endothelial cell‐specific, transfection was then achieved by incorporating the CD144 promoter. Using this system, we delivered a CXCL9 plasmid to GBM endothelium. This intervention enhanced CD8 + effector and CD4 + helper T cell representation in the TME and significantly improved responsiveness of the tumor to aPD1 checkpoint inhibition. Broadly considered, this sonoselective non‐viral transfection platform may be adapted to multiple therapeutic strategies. Further, the approach holds an advantage over AAVs with tropism for brain endothelial cells due to the ability of FUS to provide locoregional targeting specifically to brain tumor endothelium.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TransfectionBrain NeoplasmsGliomaGenetic TherapyGlioblastomaHumansAnimalsTumor MicroenvironmentNanoparticlesMiceEndothelial CellsCell Line, TumorBlood-Brain Barrier

Stichwörter der Autor:innen

brain tumorcancer researchendothelial dysfunctionendotheliumfocused ultrasoundgenetic enhancementglioma transfectiontropismtumor microenvironment

Autor:innen und Institutionen

  • Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia, USA.
  • Department of Radiology & Medical Imaging, University of Virginia, Charlottesville, Virginia, USA.

ORCID-Profile: Catherine M Gorick, Jackson Tirrell, Natasha D Sheybani, Richard J Price

Förderung

  • NIBIB NIH HHS
  • NCI NIH HHS
  • UVa Comprehensive Cancer Center
  • NINDS NIH HHS

Zitieren

APA

Debski, A. C., Gorick, C. M., Breza, V. R., Tirrell, J., Perumal, K., Nowak, K. M., Song, J., Sheybani, N. D., & Price, R. J. (2026). Sonoselective Transfection of Glioma Endothelium. Advanced Science. https://doi.org/10.1002/advs.76997

Vancouver

Debski AC, Gorick CM, Breza VR, Tirrell J, Perumal K, Nowak KM, et al. Sonoselective Transfection of Glioma Endothelium. Advanced Science. 2026. doi:10.1002/advs.76997

BibTeX
@article{Debski2026,
  author = {Debski, Anna C and Gorick, Catherine M and Breza, Victoria R and Tirrell, Jackson and Perumal, Krishan and Nowak, Katherine M and Song, Ji and Sheybani, Natasha D and Price, Richard J},
  title = {Sonoselective Transfection of Glioma Endothelium},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.76997}
}
Kostenlos starten →